Corrigendum to “Apolipoprotein A –I mimetic peptide inhibits atherosclerosis by increasing the tetrahydrobiopterin through regulating GTP-cyclohydrolase 1 and reducing uncoupled endothelial nitric oxide synthase activity” [Atherosclerosis 328 (2021) 83–91]